Thursday, May 31, 2018

MARIJUANA or HEMP CBD: Is there a difference?

By NHA
Source: nationalhempassociation.org




The Basics
Let’s start with some of the basics. Cannabidiol (Cann-uh-bid-DYE-all), most commonly referred to as CBD is one of the two most well known chemical compounds in the cannabis plant, the other being THC or tetrahydrocannabinol (te-truh-hahy-druh-kuh-nab-uh-nawl-nol). CBD is non-intoxicating meaning it will not get you “high.” THC is the chemical that gives the user the effects most commonly associated with cannabis, or marijuana.
One of the most important things to take from here is a general understanding of the difference between industrial hemp and marijuana. Industrial Hemp comes from the cannabis sativa plant and has less than a 0.03% THC content. Marijuana is either a much more potent cannabis sativa or cannabis indica, with some having over 30% THC. Yes, industrial hemp contains some THC but studies have shown that if someone would smoke industrial hemp the human body will almost always metabolize the minimal THC content before any intoxicating effects would set in.
CBD really is not anything more than extraction of cannabidiol from a cannabis plant…..that’s it. A solvent is introduced to cannabis flowers (buds) which bond to the plant’s CBD stores. After this bond takes place either a heating or cooling process normally concludes the first stage of extraction. Please keep in mind that this process has been overly simplified for the sake of argument. Studies have indicated the C02 extraction techniques have produced high grade oils without any residues like those left behind from some other extraction methods, alcohol or butane extraction for example.
 
So is there a difference?
If we think about CBD at the molecular level there is not any difference based on the source. Growing conditions and genetics play the most influential rolls in levels of contaminants and potency. So what’s the difference between marijuana and hemp derived cannabidiol? NOTHING! That’s right, there aren’t any differences. The molecular structures of CBD are the same in the various cannabis plants and/or strains. The only real difference would be in the amount of CBD various cannabis plants have.
In states that have not yet legalized medicinal marijuana, hemp derived CBD would be the only option. In states that have medical marijuana chances are you can get either. With marijuana based CBD products there will most likely be more terpenes which can affect smell, taste, and effects to the user. This change in effects is commonly due to an entourage effect caused by coupling terpenes and CBD. For example, the terpene Limonene has been shown to have positive effects on depression and anxiety by way of soothing these symptoms. Terpene profiles are much easier to tailor with marijuana as there are so many strains available compared to industrial hemp, which will likely be changing drastically in the next few years.
 
Will I fail a drug test?
CBD products come in several forms. CBD isolate does not contain any THC and there is no risk of failing a drug test. CBD that is called full spectrum contains all the cannabinoids. When derived from hemp this means there are trace amounts of THC. While not enough to get you ‘high’ if taken for extended periods of time, eventually those trace amounts may build up to levels that could result in a hot drug test. Because of the before mentioned entourage effect, full spectrum products tend to be preferred as offering the most benefit, although that has to be weighed against the risk if you intent to take it daily for long periods of time and your job requires drug testing.
But is it legal?
Hemp derived CBD is generally portrayed as ‘legal in all 50 states’ however this is not exactly true. While there is a strong case to be made that hemp derived CBD produced under a state’s lawful industrial hemp pilot program is legal, it is also true that the DEA does not currently recognize that fact. Legality of the sale and possession of CBD also depends on the state where you live. Many states accept CBD as legal and support CBD production as part of their hemp programs. There are several states where the legality of CBD is more ambiguous. And while very rare, and the cases are usually dropped, there have been some reports of people getting arrested for marijuana possession just for having CBD.
There is also a report that CJ Harris was denied his scholarship and position on the Auburn football team for his use of CBD oils to control his epilepsy. While they are now claiming the epilepsy itself is the reason, he was originally told it was his use of cannabis oil.
So is it legal? There is no question that CBD should be legal and in many places it is considered legal -but the unfortunate reality is that there simply is no clear and definitive answer. This is why we must continue to fight for federal legislation that will get CBD products out of this current gray zone. It simply benefits too many people. We encourage everyone to contact their legislators to ask them to pass federal hemp legislation.
~Nick Wicinsky, NHA Volunteer 
REFERENCES
• https://xology.co/cbd-thc-medical-marijuana/
• https://www.leafbuyer.com/blog/hemp-cbd-vs-cannabis-cbd/
• https://www.thecbdistillery.com/hemp-cbd-versus-marijuana-cbd/
• http://www.lupuschick.com/debunking-marijuana-cbd-versushemp-cbd-misconception/
• https://www.cbdvapejuice.net/differences-hemp-cbd-oilmarijuana-derived-cbd-oil/
https://www.leafly.com/news/cannabis-101/infographic-what-arecannabis-terpenes-and-how-do-they-affect-you
 
 

Hemp farmer gets permit to use federally controlled water

Source: staradvertiser.com


Kim Phillips loads a fifty-pound bag of industrial hemp seeds into her car after picking up a load of seeds from the Montana Department of Agriculture in Helena, Mont. After a year of battling federal regulations, Phillips has received a contract to use federally controlled water for irrigation.


HELENA, Mont. >> After a year of battling federal regulations, a Montana hemp farmer has a contract to use federally controlled water for irrigation.
 
Kim Phillips received the contract today, just days before she needed to plant her crop, the Independent Record reports.
 
“It really is an extraordinary day for hemp and the hemp industry,” Phillips said. “It shouldn’t take this long to get water for your hemp, it just shouldn’t.”
 
The Department of Agriculture authorized Phillips’ crop last year under Montana’s Industrial Hemp Pilot Program, which was created under the 2014 Farm Bill.
 
She planted 12 acres last spring, but the Helena Valley Irrigation District and the U.S. Bureau of Reclamation denied her water from Canyon Ferry Reservoir. The bureau bans the use of water from federal reservoirs on federally controlled substances, including hemp, which is closely related to marijuana.
 
The 2014 Farm Bill allowed states to license farmers to grow hemp for research by state agriculture departments and universities. Phillips was issued a license to grow hemp under that program, but her crop dried up because of a lack of water.

Producers look toward industrial hemp future in Montana
KPAX - Missoula, MT

Steve Davies, area manager for the Bureau of Reclamation, said today the bureau decided Phillips’ planned crop this year meets an exemption in the Farm Bill that allows hemp to be grown under an agricultural pilot program or for research.
 
“We are satisfied with the decision,” Davies said. “It’s important that we took the time and got the decision right. We had to make sure that the program she is operating under fits the exemption in the federal Farm Bill.
 
“Going forward, we will continue to evaluate these on a case-by-case basis,” he said.
 
Phillips had said she needed to plant her crop by June 1 for it to be viable.
 
 

Japan gets first outdoor billboard advertising medicinal cannabis

By Eleanor Dickinson
Source: mumbrella.asia

The first campaign advertising medicinal cannabis oil in Japan has gone live following a long-fought battle by Elixinol.




The Australian health brand has become the first to gain approval for a billboard advertising cannabidiol hemp oil – commonly known as CBD – in the country where medical marijuana has faced a fierce backlash by lawmakers.
Although CBD was legalised in November 2016, brands have so far struggled to gain approval to market their products, Elixinol Japan’s boss said in a statement.
“Japan has a very strong cultural connection with hemp, and its use by our people dates back to ancient times,” explained CEO Makoto Matsumaru.
“Elixinol has been supplying hemp oil products to Japan for over three years, however up until now we have not been able to actively market the product range. Approval to commercially advertise our Hemp Oil Drops is a major win for the hemp industry and comes after many months of working with the relevant authorities to gain authorisation.”
Created by Japanese agency Tsuge Production and Dentsu Tec, the campaign was installed in Tokyo’s Omotesando train station.
Mumbrella understands that Elixinol was able to get around the outdoor advertising regulations – which in this case are controlled by Toei Transport – owing to its conservative creative design.
Company global CEO Paul Benheim added: “Japan has the third largest consumer economy in the world, and the audience is both sophisticated and health conscious. Culturally, the Japanese people embrace natural health care, and with an aging population there is huge interest in preventative health and wellness through clinical grade CBD supplements.”














The Hemp Farming Act of 2018 May Mean a Boost in Agricultural Prosperity

By Justice Council
Source: leafbuyer.com


Man examines leaves in a hemp field

Those involved in the already booming hemp industry have their fingers crossed as federal legalization gets closer and closer to reality. There is finally a new Hemp Bill that will actually make a difference in our society. The Hemp Farming Act of 2018 would bring our Nation back the good old days when industrial hemp was one of the leading agricultural crops in the United States. In 1850, the state of Kentucky alone was producing more than 40,000 tons of hemp each year. We were using hemp for paper, clothing, plastic, construction materials, and even food. 
Think of all of the different industries that had to adapt to the prohibition of cannabis and industrial hemp. The Hemp Farming Act of 2018 is the first step toward reviving our nation’s once-thriving agricultural crop and bringing regulation to an industry that is in dire need of compliance.  

What is The Hemp Farming Act of 2018? 

The Senate Majority Leader, Mitch McConnell, has been a proponent of agricultural hemp since The Agricultural Act of 2014. This bill allowed states and institutions of higher education to grow hemp for conducting research and to test pilot hemp programs. After watching Kentucky’s Industrial Hemp Research Program very closely, McConnell was pleased with the pilot’s progress and accomplishments. This led him to support The Hemp Farming Act of 2018. 
McConnell recently announced he will introduce legislation to declassify industrial hemp as a schedule 1 substance under The Hemp Farming Act of 2018. This is a bill that is designed to bring back the agricultural wealth of industrial hemp in several industries, including construction, plastic, paper, clothing, cosmetics, and even the automotive industry. While the legalization of industrial hemp is the backbone of this bill, there are some strict, but necessary, compliance regulations that come with it. 

Definition of The Hemp Farming Act of 2018 

“THE CONGRESS FINDS THAT INDUSTRIAL HEMP IS A NON-NARCOTIC AGRICULTURAL COMMODITY THAT IS USED IN TENS OF THOUSANDS OF LEGAL AND LEGITIMATE PRODUCTS.” 
Above is the Section 2. Finding of The Hemp Farming Act of 2018. Simplified, the finding means industrial hemp would no longer be considered a schedule 1 drug. However, the bill continues and states that the term ‘marijuana’ does not include industrial hemp or research hemp. It also states, under the definition of industrial hemp, that all industrial hemp must have less than 0.3% of delta-9 THC on a dry weight basis 
Other Contingencies to the Term Industrial Hemp:  
  • The production, storage, distribution, and use of industrial hemp must be lawful under the state law or tribal jurisdiction.  
  • Any person/persons responsible for production, storage, and distribution of industrial hemp must submit their namesperiod of time that their current license allows them to operate, and any information pertaining to each location where the above conduct is authorized to occur.  
  • The term industrial hemp does not include any plant that has been bred to increase the percentage of delta-9 THC above the specified limit of 0.3% THC.  
The bill delves into the difference between industrial hemp and research hemp. Research hemp is only permitted to be used in scientific, medical, or industrial research. Unlike industrial hemp, research hemp is allotted to have more than 0.3% THC but must be less than 0.6% THC on a dry weight basis. The most important difference between research hemp and industrial hemp is that research hemp can never be used as a commodity.  

Compliance Regulations of The Hemp Farming Act of 2018 

The Hemp Farming Act of 2018, under Section 4. Administrative Inspections, states that any land or warehouses where industrial and research hemp is produced, stored, distributed, or used will be required to allow reoccurring inspections to ensure compliance with the requirements of this Act. Similar to how certain states regulate their recreational marijuana, industrial hemp will now need to follow similar rules as more and more checks and balances are put in place.  
Along with passing regular compliance checks, The Hemp Farming Act of 2018 also states that this bill does not alter any provisions of the Federal Food, Drug, and Cosmetic Act. This simply states that all industrial hemp products must not contain any unapproved ingredients, adulterated content, or misbranded drug or food content. 

What to Expect 

The Hemp Farming Act of 2018 would be a major step for the federal government and cannabis. So far, this bill has not been presented to the Senate, but it is in the process of being reviewed by multiple subcommittees.  The bill was first introduced in the House in July 2017. A year later, it is safe to say that this bill should be introduced to the Senate sometime soon. Alterations will, most likely, be made and more detailed regulations will be added the Act. However, as long as industrial hemp is declassified as a schedule 1 drug, then The Hemp Farming Act of 2018 is a win.  
 

THE CANNABIS BUSINESS BANKING CRISIS

Editorial
By Rachelle Lynn Gordon
Source: thecannabisindustry.org


The fledgling legal cannabis industry has faced numerous challenges since California voters made the state the first to approve the plant for medical use in 1996. Since then, an additional 29 states and the District of Columbia have legalized cannabis for either medical and/or adult-use purposes yet it still remains a Schedule I controlled substance in the eyes of the federal government. This has caused immense headaches for cannabis business owners in a multitude of ways – especially when it comes to balancing the books. The majority of traditional banking institutions refuse to work with clients that touch the plant, leaving many businesses to operate as cash-only while at the same time missing out on the traditional financial and lending opportunities given to other businesses.
pexels“Being forced to hire an armored truck just to pay taxes or provide payroll isn’t only a hassle – it’s also extremely dangerous,” says Harry Resin, who longs for the day when he can open a business checking account for his cannabis company, URB Delivery. “People’s livelihoods – and frankly their lives – are constantly at risk when you’re dealing with large amounts of currency.”
Lack of security isn’t the only detriment to cannabis business owners unable to find banks who will work with them. Business loans, savings accounts, 401Ks, and credit lines are all out of reach for those wishing to develop their operations and plan for the future.
“I would love to be able to expand my operations but because I don’t have the option to take out a small business loan, I either have to get loans from friends and families or potentially give up equity to private investors,” Resin adds. “It makes things difficult.”
While many believe that it is illegal for banks to do business with those in the marijuana space, it turns out the opposite is true.
“We actually have regulations on how to bank the cannabis industry, but most banks don’t want to go through the expense and hassle of opening new departments,” explains Jim Marty, CEO of Bridge West CPA. “They’re already making tons of money, so they don’t feel the need to enter a new space. It’s going to take Congressional action on legalization before the big players enter in.”
While it’s not clear how exactly cannabis reform will play out, Marty cautions that while moving cannabis to Schedule II status could be positive for advocates of legalization, it may also negatively affect the entrepreneurial activity the emerging cannabis industry has shown.
“Right now, we have a lot of start-ups and small businesses that are getting funding from angel investors or private equity funds. If cannabis becomes Schedule II, there’s a chance that Big Pharma, Big Tobacco, and Big Alcohol will come in and there will be two or three major producers. So something that could fix a lot of the problems may do more harm than good.”
Marty notes that the introduction of bills such as The SAFE (Secure and Fair Enforcement) Banking Act (S. 1152, H.R. 2215), which would offer protections for state-legal financial institutions working with marijuana businesses, are steps in the right direction for the cannabis industry but that it is going to take hard work and perseverance by all in the community before real change is made.
Help us grow even more support for the SAFE Banking Act in Congress. Contact your members of Congressand urge them to support federal protections for financial institutions that work with the regulated cannabis industry.

Sunday, May 27, 2018

Parents Treating Kids With Cannabinoid Oil Could Lose Them

By Katie MacBride
Source: thedailybeast.com

silhouette image of an adult leading a child by the hand background marijuana leaves forefront closeup of gloved hand holding cbd oil

PHOTO ILLUSTRATION BY THE DAILY BEAST


They gave their six-year-old a couple drops of oil to help treat her epilepsy. Child Protective Services, though, was at their door.


In April, a committee at the Food and Drug Administration took the unprecedented step to recommend for approval Epidiolex, an epilepsy drug containing a plant-sourced cannabinoid, cannabidiol (CBD). In June, the FDA will vote on approving the drug, which has been shown in limited studies to be effective for those suffering from severe epilepsy.
Maria Selva’s seven-year-old daughter, Aliana, has epilepsy and has found relief from seizures with CBD.
But treating her daughter’s seizures with CBD has put Selva at significant risk, and she has mixed feelings about the FDA’s potential approval of Epidiolex. In October 2017, Child Protective Services charged Maria and her husband with “severe medical neglect,” and removed Aliana from her parents’ care.
Aliana Selva was six-years-old and on vacation with her family in Los Angeles when she had her first tonic-clonic seizure. She had experienced a few mild seizures as an infant, but the doctors assured Maria and her husband, Jo Selva, that these seizures were common and she would likely grow out of them. For nearly four years, the Selvas thought the doctors were right.
Then, on March 31, 2016, Aliana had two seizures.
The Selvas rushed Aliana to the emergency room, where she was examined and released. The doctor said the hospital would forward the exam notes to a neurologist in the Bay Area, where the Selvas lived. When they returned home, a neurologist called and said Aliana needed to be put on the anticonvulsant drug, Keppra.
“I remember asking her, so, is there a diagnosis?” Maria says. “It just seemed so strange, we didn’t even know what was wrong but we were already putting her on medication for it.”
Within a few minutes of giving Aliana the first dose of the drug, Aliana’s personality transformed dramatically.
“Ali’s normally a very sweet, gentle little girl,” Maria says, “After giving her that first dose of Keppra, she was super aggressive and irritable. She went from jumping on the bed, saying she wanted to have a dance party to sobbing and banging her head against the wall. She didn’t care that she was hurting herself. It was completely outside her personality. It was insane. It wasn’t Ali.”
“Keppra rage,” Dr. Bonni Goldstein, former Chief Resident at Los Angeles Children’s Hospital, said immediately when she heard Ali’s story (Aliana goes by both her full name and the nickname). Goldstein hasn’t treated the Selvas and wasn’t previously familiar with their case, but she has dealt with her share of children with epilepsy, both on and off Keppra. She practiced pediatric emergency medicine for thirteen years before switching gears to focus on cannabinoid therapies. Goldstein has seen Keppra work well for many patients, and she’s seen many others have precisely the reaction Maria described.
The possible behavioral side effects of Keppra in children are well documented, including hostility and aggression.  
Maria took Ali off of  the drug after a week. “I was uncomfortable with the whole thing,” Maria said. “We didn’t have a diagnosis, no one explained to me how this medication was supposed to work, how long she needed to be on it, anything.” They hadn’t even met the doctor who prescribed it.
Over the next year, Ali had a handful of absence seizures (characterized by brief lapses in attention, absence seizures usually last 1-2 minutes). A neurologist diagnosed Ali with epilepsy—the first diagnosis she’d received—and ordered an MRI. The results were normal (Normal results for MRIs and/or EEGs are not uncommon in cases of epilepsy).
In May 2017, the Selvas moved to Southern California. That summer, there was a slight uptick in the frequency of Ali’s absence seizures. This development worried the Selvas, but Keppra seemed like an extreme response. Years earlier, they had heard about treating seizures with CBD oil, a non-psychoactive compound found in cannabis. But Maria said, “as soon as I heard it had to do with marijuana, I brushed it off.”
Now, however, desperate for alternatives to Keppra, they started looking into CBD. It had been covered in the national media in 2013 when Charlotte Figi, a six-year-old with a severe form of epilepsy, dramatically improved after using the oil. “There was so much research about how CBD was non-psychoactive and helpful for kids like Ali,” Maria said. And crucially, there were no significant side effects.  A veterinarian friend told Jo about the success she’d had treating epileptic animals with CBD oil. A health store near their home sold CBD oil, so they decided to give it a try. It wasn’t FDA approved, they understood that. But it was better than their child banging her head against the wall in rage.
In July of 2017, Ali started a very low dose of CBD oil, administered orally. “We were really cautious,” Maria said. “For the first few weeks, we only gave her two drops per day. We found out later that the dose was too low to have any impact, but we wanted to start slow.”
bottles of cbd oil from marijana framed by leaves

SHUTTERSTOCK

At the end of the first week of school, Ali had a brief absence seizure in class. A few after,  , Ali had a much more extreme (tonic-clonic) seizure. Maria brought Ali to the emergency room, where she seized a second time. “She wet herself; she may have been biting her tongue,” Maria recalls. “It was awful.”
Frightened by this sudden escalation, the Selvas reluctantly consented to a restarting a daily dose of Keppra IV to stop the seizing. At the same time, they  also increased Ali’s dose of CBD.
Once again, the “Keppra rage” returned; Ali was, according to Maria,  “hyper, aggressive, clumsy.” Within a week, the Selvas decided to stop administering Keppra. When the Selvas met with a neurologist the following week, they asked about alternatives to the medication; he refused to discuss alternative treatments with them. “This [Keppra] is what she should take; if you don't like it and you want something natural, you need to go somewhere else,” Maria later texted a friend.
Dr. Julie Griffith, a neurologist in San Rafael, California, isn’t familiar with the Selvas case and therefore couldn’t comment on it directly, but she stresses that if one medication doesn’t work for a patient, a neurologist could suggest several other medications that might be better tolerated. According to the Selvas, no such offer was made.
Intent on finding someone who could talk to them about alternatives, the Selvas switched insurance companies. The Selvas also met  with school administrators and agreed on a plan regarding Ali’s seizures: If she had one that lasted less than five minutes, the school would call her parents to come pick her up. If it lasted more than five minutes, they’d call the Selvas and an ambulance.
Two weeks later, the plan was enacted. Ali had an absence seizure in class and Jo came to pick his daughter up from school, telling staff they were using CBD oil and looking for a new neurologist after switching insurance plans.
Several days later, Maria received a call from Loretta Lopez of Child Protective Services.
CPS wanted to do a home inspection and assess the safety of Ali’s home environment. “It didn’t sit well with us,” Maria says, “but we also thought, let’s invite them in and show them that we have nothing to hide.”
During the inspection, the Selvas recounted Ali’s medical history and Lopez asked to see the medication Ali was taking. The Selvas produced both the Keppra and the CBD oil, and informed Lopez that they were only using the CBD oil. (The Daily Beast tried to contact Lopez for this story, but the County of Orange Social Services Agency declined on her behalf “due to state confidentiality laws.”)
Maria thought it went well. “She [Lopez] seemed like she was on our side. She kept saying, ‘I know there’s a reason for everything you’re doing, I just want to help you make that clear.’ She told us that she’d get back to us Tuesday or Wednesday with a report.” Maria signed a form saying CPS could access Ali’s medical files as well as a “safety plan” affirming that they would take Ali to the hospital if she had a seizure.
It was an unsettling experience, but the Selvas were more confused than scared. “I figured she was just going to call Tuesday or Wednesday and say everything you said checks out, case closed.’”
Maria was wrong. The following Wednesday, Lopez called Maria saying they needed to have an urgent, in-person meeting. Maria was confused: In her mind, they’d done everything to be accomodating:They’d given permission for CPS to view Ali’s medical records and to speak with her doctor; they’d allowed CPS into their home, shown them the kids’ living environment, and met both parents. How could Lopez still have concerns about her kids’ safety?
chemical symbol of cannabidiol cbd marijuana leaf in forefront green

SHUTTERSTOCK

The Selvas agreed to meet, but said they wanted an attorney present. This, they were told, was against CPS policy. “You can bring anyone you want,” a senior social worker told the Selvas, “just not an attorney.”
The policy of prohibiting attorneys at “team meetings” is standard in California. Orange County Social Services wouldn’t comment on any particular case but directed The Daily Beast to their policy regarding attorneys at team meetings here.
Without the protection of a lawyer, the Selvas felt like they needed more time to understand what they were potentially up against. Could they have the meeting over the weekend or the following Monday instead?
‘That won’t work,” Maria recalls the social worker saying, “We’re just going to go ahead and get Juvenile Dependency Court involved.”
“For what?” Maria recalled asking. “We don’t even know what the results of your investigation are or what we’re being charged with.”
The meeting was supposed to be when they found out all that information, the Selvas were told. But by refusing to meet that day without an attorney, the social worker told them, they were “choosing not to participate” and CPS “had no other choice but to move forward with getting a warrant and Juvenile Court.”
When the call ended, Jo and Maria immediately started contacting lawyers. “We were so in the dark,” Maria says. “They said they were going to get a warrant, but for what?”
In retrospect, Maria sees her confusion as naivete. “In this perfect world you picture, you have to be a bad parent to get your child taken away.”
The following evening, Maria and Jo Selva’s child was taken away.
The knock came just after 8 PM on Saturday, October 28. Through the peephole, Maria saw three police officers outside her door. They said they were doing a welfare check.
That’s when Maria started streaming the incident on Facebook Live. In the video, Jo speaks to the police officers through the closed door. He asks what a welfare check entails, and asks if they have a warrant. The officer explains that they don’t need a warrant for a welfare check. Jo says he and Maria will come outside to talk, but are going to close the door behind them. The police agree. The video is dark, but seconds after opening the door, Jo is handcuffed.
Once in handcuffs, the police tell Jo that they do have a warrant, one that allows them to take Ali into protective custody. The officers read the warrant to the handcuffed Jo and he pleads, “she’s going to freak out if she doesn’t have us by her side. She’s epileptic and everytime she gets anxiety she has seizures.”
bottle and sample box of epidiolex

PUBLIC DOMAIN

The video is over an hour long and concludes with Maria asking Ali, who appears unperturbed and smiling, dressed in Strawberry Shortcake pajamas, what she wants to bring with her to go “spend the night somewhere really nice.”
Ali spent the next three nights at Orangewood Children’s Home in Orange County. Her parents were allowed one supervised 30 minute visit per day. On the second day, Ali started asking to go home. “It had stopped being this adventure for her, Maria said. “Her hair wasn’t brushed and her breath was stinky. I wanted to ask if she was brushing her teeth and everything, but it’s hard.When you only have 30 minutes with your child, are you really going to talk about brushing teeth? She kept asking why she couldn’t come home. I kept saying, ‘I’m sorry; I’m working on it.’”
Epidiolex, the drug which is set for FDA approval, is a product of GW Pharmaceuticals. The FDA was impressed with positive results from three randomized, double-blind, placebo-controlled trials. The drug will likely be approved for patients with Lennox-Gastaut syndrome and Dravet syndrome, two severe, rare forms of epilepsy. While Aliana's epilepsy is not severe enough to meet the expected criteria for the drug, the studies indicate the therapeutic potential of cannabidiol in treating seizure disorders.
Allison Ray Benavides, a social worker in San Diego and mother of an epileptic child believes that CPS is targeting vulnerable families with these cases. She told The Daily Beast, “in San Diego, there’s a group of us moms who have kids with seizure disorders and use CBD oil. There’s only one mom in our group who has had a problem with CPS: the single mom whose husband is in prison.” She believes the Selvas were vulnerable in a different way, “you can draw a clear line from CPS to this young, hispanic family living in a very conservative county (Orange County). If they were white and living in Newport Beach, this never would have happened.”
This rings true to Ursula Kilmer, of Redding, California. She’s been battling CPS for the same reason as the Selvas. Kilmer’s son has Lennox-Gastaut Syndrome (a severe form of epilepsy). When she was able to use CBD oil in lieu of other anticonvulsants, “His seizures stopped completely.” But CPS alleges medical neglect, and Kimler has been ordered to put her son back on drugs that do not prevent his seizures and, she believes, makes them worse.
 
Kimler has spent the last nine months trying to appease CPS and have the courts condone her use of CBD oil. “I’m exhausted,” she says, “I just want to be able to give my kid the stuff that helps him.”
On November 1, three days after she was taken, the Selvas were granted temporary custody of their daughter and saw, for the first time, what the official charges against them were: “Severe medical neglect.”
Griffith is among the neurologists who think CBD is promising for many cases, but has concerns about the unregulated market and quality control. She also believes more research needs to be done on the effect of CBD on developing brains. That said, when presented with a hypothetical situation in which a parent is treating their child’s seizures with CBD oil, Griffith said, “If they’re trying to treat the seizures, that certainly doesn’t sound like neglect.”
On December 5, 2017, the Selva’s case was dismissed by Juvenile Dependency Court.
To this day, the Selvas don’t know for sure who reported them to CPS. Goldstein understands the confusion that mandated reporters like school nurses and social workers have about cannabinoid therapies. It’s one of the reasons she’s started an educational program for people who are in a position to intervene.
Goldstein—who stressed that she is a physician unassociated with the cannabis industry— adamantly believes that “[cannabis] must be treated the way you’d treat any other prescription drug; if a family is being responsible and has medical supervision, and is using cannabis to treat a medical condition, you should not call Child Protective Services on them because that is absolutely not neglect.”
As for Aliana, she’s seeing a new neurologist who understands the efficacy of CBD for seizure disorders and is monitoring her closely. Emotionally, however, the trauma of the ordeal lingers. She gets scared at night now, something that never happened before.
Maria understands how she feels. “I thought as a parent, I had rights,” Maria said., “Now there’s this fear that CPS could just come through the door and take my kids away.”